Global Point of Care Molecular Diagnostics Market, By Product & Services (Assays & Kits, Instruments/Analyzers, Software & Services), Technology (PCR-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based, INAAT, Others), Test Location (OTC, POC), Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-Acquired Infections, Oncology, Hepatitis, Hematology, Prenatal Testing, Endocrinology, Others), End User (Physician Offices, Hospital Emergency Departments & Intensive Care Units, Research Institutes, Home-Care, Decentralized Labs, Assisted Living Healthcare Facilities, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027
Market Analysis and Insights of Global Point of Care Molecular Diagnostics Market
Point of care molecular diagnostics market is expected to reach a market value of USD 5.12 billion by 2027 growing at a CAGR of 12.9% in the forecast period of 2020-2027. The growing awareness regarding the testing methods among patients has been directly impacting the growth of point of care molecular diagnostics market.
Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027. On the other hand, few factors that will create opportunities for the growth of the market are increasing growth of POC molecular diagnosis in emerging countries such as India, China and Brazil along with rising research and development activities in molecular diagnosis.
Lack of reimbursement policies and stringent rules and regulations along with increasing procedure costs are act as market restraints for point of care molecular diagnostics market in the above mentioned forecast period.
This point of care molecular diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research point of care molecular diagnostics market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point of Care Molecular Diagnostics Market Scope and Market Size
Point of care molecular diagnostics market is segmented on the basis of product & services, technology, test location, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product & services, point of care molecular diagnostics market is segmented into assays & kits, instruments/analyzers, software & services.
- Point of care molecular diagnostics market has also been segmented based on the technology into PCR-based, genetic sequencing-based, hybridization-based, microarray-based, INAAT and others.
- Based on test location, point of care molecular diagnostics market is segmented into OTC and POC.
- Based on application, point of care molecular diagnostics market is segmented into respiratory diseases, sexually transmitted diseases, hospital-acquired infections, oncology, hepatitis, hematology, prenatal testing, endocrinology and others.
- Based on end-user, point of care molecular diagnostics market is segmented into physician offices, hospital emergency departments & intensive care units, research institutes, home-care, decentralized labs, assisted living healthcare facilities and others.
Point of Care Molecular Diagnostics Market Country Level Analysis
Point of care molecular diagnostics market is analysed and market size insights and trends are provided by country, product & services, technology, test location, application and end user as referenced above.
The countries covered in the point of care molecular diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the point of care molecular diagnostics market because of increasing demand of diagnosis and development of new test for DNA analysis, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to increasing population and cost effective molecular test.
The country section of the point of care molecular diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Point of care molecular diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care molecular diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care molecular diagnostics market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Point of Care Molecular Diagnostics Market Share Analysis
Point of care molecular diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point of care molecular diagnostics market.
The major players covered in point of care molecular diagnostics market report are Abbott, Danaher., bioMérieux SA, F. Hoffmann-La Roche Ltd, Quidel Corporation, Meridian Bioscience, Inc., Mesa Biotech, Inc, GenePOC Inc., Spartan Bioscience Inc., Biocartis, Siemens Healthcare Private Limited, BD, Bio-Rad Laboratories, Inc., Cepheid, Abaxis, OraSure Technologies, Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., VIRCELL S.L., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Point of Care Molecular Diagnostics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.